At Bokhari Medical Consortium we offer Spravato treatment for Major Depressive Disorder and Treatment Resistant Depression (TRD). Spravato is the active ingredient in Esketamine; an approved drug by the Food and Drug Administration (FDA) for the use of an anesthetic.
Here at Bokhari Medical consortium, we pride ourselves on delivering exceptional healthcare services with a commitment to patient well-being. Psychiatrist, Autism, ADHD, Depression, Addiction, Anxiety, OCD, Bipolar, BEMER Therapy, PEMF Therapy, Ketamine Therapy, TMS (Transcranial Magnetic Stimulation) Therapy, Spravato (Esketamine) treatments, Hyperbaric Oxygen Therapy, Medication Management, Neuropsychiatric, Telepsychiatry, QB Testing, Red Light Therapy and more.









